Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saba Jafarpour

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Epilepsy & Behavior : E&B|April 17, 2016
Effectiveness of once-daily high-dose ACTH for infantile spasmsRyan M Hodgeman, Kush Kapur, Ann Paris, et al.
Orphanet Journal of Rare Diseases|March 15, 2025
Caregiver burden and familial impact in Down Syndrome Regression DisorderKatherine Chow, Panteha Hayati Rezvan, Lilia Kazerooni, et al.
Pediatric Neurology|October 8, 2022
Prevalence and Predictors of Seizure Clusters in Pediatric Patients With Epilepsy: The Harvard-Yale Pediatric Seizure Cluster StudySaba Jafarpour, Michael W K Fong, Kamil Detyniecki, et al.
Frontiers in Neurology|December 22, 2023
Impact of endocrine dysregulation on disability and non-motor symptoms in pediatric onset multiple sclerosisJustin Abe, Saba Jafarpour, My H Vu, et al.
Annals of Clinical and Translational Neurology|February 25, 2025
Evidence of blood-brain barrier dysfunction and CSF immunoglobulin synthesis in Down Syndrome Regression DisorderJonathan D Santoro, Neetha Paul Eduthan, Mellad M Khoshnood, et al.
Scientific Reports|December 28, 2024
Diagnostic abnormalities, disease severity and immunotherapy responsiveness in individuals with Down syndrome regression disorderJonathan D Santoro, Saba Jafarpour, Laura Keehan, et al.
American Journal of Medical Genetics. Part A|January 3, 2024
Safety and tolerability of intravenous immunoglobulin infusion in Down syndrome regression disorderJonathan D Santoro, Saba Jafarpour, Mellad M Khoshnood, et al.
Neurology and Therapy|March 8, 2026
A Comparative Effectiveness Study of Lorazepam or IVIg Versus no Treatment for Down Syndrome Regression DisorderJonathan D Santoro, Saba Jafarpour, Panteha Hayati Rezvan, et al.
Journal of Neurology|June 22, 2024
De novo variants in immune regulatory genes in Down syndrome regression disorderSaba Jafarpour, Abhik K Banerjee, Mellad M Khoshnood, et al.
Annals of Clinical and Translational Neurology|February 20, 2024
Neuroimaging abnormalities associated with immunotherapy responsiveness in Down syndrome regression disorderJonathan D Santoro, Mellad M Khoshnood, Saba Jafarpour, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Epilepsy & Behavior : E&B|April 17, 2016
Effectiveness of once-daily high-dose ACTH for infantile spasmsRyan M Hodgeman, Kush Kapur, Ann Paris, et al.
Orphanet Journal of Rare Diseases|March 15, 2025
Caregiver burden and familial impact in Down Syndrome Regression DisorderKatherine Chow, Panteha Hayati Rezvan, Lilia Kazerooni, et al.
Pediatric Neurology|October 8, 2022
Prevalence and Predictors of Seizure Clusters in Pediatric Patients With Epilepsy: The Harvard-Yale Pediatric Seizure Cluster StudySaba Jafarpour, Michael W K Fong, Kamil Detyniecki, et al.
Frontiers in Neurology|December 22, 2023
Impact of endocrine dysregulation on disability and non-motor symptoms in pediatric onset multiple sclerosisJustin Abe, Saba Jafarpour, My H Vu, et al.
Annals of Clinical and Translational Neurology|February 25, 2025
Evidence of blood-brain barrier dysfunction and CSF immunoglobulin synthesis in Down Syndrome Regression DisorderJonathan D Santoro, Neetha Paul Eduthan, Mellad M Khoshnood, et al.
Scientific Reports|December 28, 2024
Diagnostic abnormalities, disease severity and immunotherapy responsiveness in individuals with Down syndrome regression disorderJonathan D Santoro, Saba Jafarpour, Laura Keehan, et al.
American Journal of Medical Genetics. Part A|January 3, 2024
Safety and tolerability of intravenous immunoglobulin infusion in Down syndrome regression disorderJonathan D Santoro, Saba Jafarpour, Mellad M Khoshnood, et al.
Neurology and Therapy|March 8, 2026
A Comparative Effectiveness Study of Lorazepam or IVIg Versus no Treatment for Down Syndrome Regression DisorderJonathan D Santoro, Saba Jafarpour, Panteha Hayati Rezvan, et al.
Journal of Neurology|June 22, 2024
De novo variants in immune regulatory genes in Down syndrome regression disorderSaba Jafarpour, Abhik K Banerjee, Mellad M Khoshnood, et al.
Annals of Clinical and Translational Neurology|February 20, 2024
Neuroimaging abnormalities associated with immunotherapy responsiveness in Down syndrome regression disorderJonathan D Santoro, Mellad M Khoshnood, Saba Jafarpour, et al.
Pageof 6